Formulation

hydrogels as cell encapsulants

Characterization of Hydrogel Carriers: Improving the Efficacy of Existing Cell Therapies Characterization of Hydrogel Carriers: Improving the Efficacy of Existing Cell Therapies

+1

byStella Vnook, Megan Hamiltonand 1 more

Apr 10, 2024

Continued Process Verification: A Multivariate, Data-Driven Modeling Application for Monitoring Raw Materials Used in Biopharmaceutical Manufacturing

Biochemicals/Raw Materials

Continued Process Verification: A Multivariate, Data-Driven Modeling Application for Monitoring Raw Materials Used in Biopharmaceutical Manufacturing Continued Process Verification: A Multivariate, Data-Driven Modeling Application for Monitoring Raw Materials Used in Biopharmaceutical Manufacturing

byHao Wei, John Masonand 1 more

Jun 26, 2023

Advances Toward Dry-Powder Formulations for Monoclonal Antibodies

Advances Toward Dry-Powder Formulations for Monoclonal Antibodies Advances Toward Dry-Powder Formulations for Monoclonal Antibodies

byBrian Gazaille, Robert O. Williams III

Mar 21, 2023

Container Materials for Biopharmaceuticals: A Comparative Small-Scale Case Study of Stainless Steel and a Proprietary Nickel-Based Alloy

Container Materials for Biopharmaceuticals: A Comparative Small-Scale Case Study of Stainless Steel and a Proprietary Nickel-Based Alloy Container Materials for Biopharmaceuticals: A Comparative Small-Scale Case Study of Stainless Steel and a Proprietary Nickel-Based Alloy

bySonia Bedi, Mintai Peter Hwangand 5 more

Dec 12, 2022

Rapid Screening of Bioavailability: Enhancing Technologies to Accelerate Time to Clinic

Sponsored Content

Rapid Screening of Bioavailability: Enhancing Technologies to Accelerate Time to Clinic Rapid Screening of Bioavailability: Enhancing Technologies to Accelerate Time to Clinic

byBPI Contributor

Aug 24, 2022

Nonideal Colligative Properties in High-Concentration MAb Solutions

Nonideal Colligative Properties in High-Concentration MAb Solutions Nonideal Colligative Properties in High-Concentration MAb Solutions

byAlona Teran, Sabaha Khakooand 2 more

Dec 8, 2021

Formulation, Fill and Finish of Lentiviral Vectors: Part 1 — Case Study in Facility and Process Design

Facility Design/Engineering

Formulation, Fill and Finish of Lentiviral Vectors: Part 1 — Case Study in Facility and Process Design

Formulation, Fill and Finish of Lentiviral Vectors: Part 1 — Case Study in Facility and Process Design

byLeslie Southam, James L. Drinkwater

Sponsored Content

Spurring on Innovation in Gene Therapy Development

Spurring on Innovation in Gene Therapy Development

+1

byBrian Gazaille, Roland W. Herzogand 1 more

Aseptic Considerations in Formulation, Fill and Finish: Choosing Between Barrier and Isolator Technologies

Aseptic Considerations in Formulation, Fill and Finish: Choosing Between Barrier and Isolator Technologies

Aseptic Considerations in Formulation, Fill and Finish: Choosing Between Barrier and Isolator Technologies

byPatrick Nieuwenhuizen

Creative Formulation: A Useful Approach to Patient-Centered Drug Development

Creative Formulation: A Useful Approach to Patient-Centered Drug Development

Creative Formulation: A Useful Approach to Patient-Centered Drug Development

Analysis of Trace-Level, High-Risk HCPs: Proteomics Advances for Preventing Degradation of Polysorbates in Biotherapeutic Formulations

Product Characterization

Analysis of Trace-Level, High-Risk HCPs: Proteomics Advances for Preventing Degradation of Polysorbates in Biotherapeutic Formulations

Analysis of Trace-Level, High-Risk HCPs: Proteomics Advances for Preventing Degradation of Polysorbates in Biotherapeutic Formulations

byXuanwen Li, Douglas D. Richardson

Single-Use Technology for Formulation and Filling: A Case Study from Swissfillon AG and Pall Corporation

Sponsored Content

Single-Use Technology for Formulation and Filling: A Case Study from Swissfillon AG and Pall Corporation

Single-Use Technology for Formulation and Filling: A Case Study from Swissfillon AG and Pall Corporation

byDelphine Lallement

Eradicating the Need for Cold-Chain Distribution in the Biopharmaceutical Industry

Sponsored Content

Eradicating the Need for Cold-Chain Distribution in the Biopharmaceutical Industry

Eradicating the Need for Cold-Chain Distribution in the Biopharmaceutical Industry

byShalabh Jain, Sowmya V. Kulal

Sponsored Content

Ask the Expert: Formulation Strategies for AAV-Based Gene Therapies

Ask the Expert: Formulation Strategies for AAV-Based Gene Therapies

byBPI Contributor

Stability Testing: Monitoring Biological Product Quality Over Time

Stability Testing: Monitoring Biological Product Quality Over Time

Stability Testing: Monitoring Biological Product Quality Over Time

byCheryl Scott, Nadine Ritter

eBook: Formulation, Fill–Finish — Biopharmaceutical Drug-Product Trends and Technologies

eBook: Formulation, Fill–Finish — Biopharmaceutical Drug-Product Trends and Technologies

eBook: Formulation, Fill–Finish — Biopharmaceutical Drug-Product Trends and Technologies

byCheryl Scott, Brian Gazaille

Sponsored Content

Ask the Expert: Translating Inhaled and Nasal Technologies for Biologics Delivery

Ask the Expert: Translating Inhaled and Nasal Technologies for Biologics Delivery

byBPI Contributor

Ask the Expert: Ultrapure Gelatin Can Optimize Your Excipient Screening for Vaccine Formulation

Sponsored Content

Ask the Expert: Ultrapure Gelatin Can Optimize Your Excipient Screening for Vaccine Formulation

Ask the Expert: Ultrapure Gelatin Can Optimize Your Excipient Screening for Vaccine Formulation

byBPI Contributor

Are You Missing the Bigger Picture with Your AAV Analytics? Fast, Low-Volume Subvisible Particle Analysis for Characterizing Viral Vectors

Sponsored Content

Are You Missing the Bigger Picture with Your AAV Analytics? Fast, Low-Volume Subvisible Particle Analysis for Characterizing Viral Vectors

Are You Missing the Bigger Picture with Your AAV Analytics? Fast, Low-Volume Subvisible Particle Analysis for Characterizing Viral Vectors

byRenee Tobias, Gabriel Mercado

Biopharmaceutical Product Specification Limits and Autocorrelated Data

Product Characterization

Biopharmaceutical Product Specification Limits and Autocorrelated Data

Biopharmaceutical Product Specification Limits and Autocorrelated Data

byKeith M. Bower

eBook: Biologics Stability — Lifecycle Management of Drug Products

eBook: Biologics Stability — Lifecycle Management of Drug Products

eBook: Biologics Stability — Lifecycle Management of Drug Products

Formulation Development of Microbiome Therapeutics Localized in the Intestines

Formulation Development of Microbiome Therapeutics Localized in the Intestines

Formulation Development of Microbiome Therapeutics Localized in the Intestines

+1

byAndrew Bristol, Steven Hubertand 1 more

Introduction: Drug Product Discussions

Introduction: Drug Product Discussions

Introduction: Drug Product Discussions

Analytical Strategies for Fixed-Dose Coformulated Protein Therapeutics

Analytical Strategies for Fixed-Dose Coformulated Protein Therapeutics

Analytical Strategies for Fixed-Dose Coformulated Protein Therapeutics

+3

byGeorge Svitel, Olivier Mozziconacciand 3 more

Early Stage Development of Advanced Formulations in the Drug Development Process Provides Competitive Advantages: Survey Predicts That Drug Product

Early Stage Development of Advanced Formulations in the Drug Development Process Provides Competitive Advantages: Survey Predicts That Drug Product Formulation Recognition and Budgets Will Increase Significantly

Early Stage Development of Advanced Formulations in the Drug Development Process Provides Competitive Advantages: Survey Predicts That Drug Product Formulation Recognition and Budgets Will Increase Significantly

+4

byBirgit Schwab, Konstantin Petropoulosand 4 more

Apparent Matrix Effects in an Iduronate 2-Sulfatase Specific Activity Assay

Apparent Matrix Effects in an Iduronate 2-Sulfatase Specific Activity Assay

Apparent Matrix Effects in an Iduronate 2-Sulfatase Specific Activity Assay

+1

byTakayuki Nakano, Brenda Kelloggand 1 more

March 2019 Featured Report

March 2019 Featured Report

March 2019 Featured Report

Rational Selection of Sugars for Biotherapeutic Stabilization: A Practitioner’s Perspective

Rational Selection of Sugars for Biotherapeutic Stabilization: A Practitioner’s Perspective

Rational Selection of Sugars for Biotherapeutic Stabilization: A Practitioner’s Perspective

Development of a Freeze-Dried Ebola-Expressing Adenoviral Vector: Unexpected Findings and Problems Solved

Development of a Freeze-Dried Ebola-Expressing Adenoviral Vector: Unexpected Findings and Problems Solved

Development of a Freeze-Dried Ebola-Expressing Adenoviral Vector: Unexpected Findings and Problems Solved

byFrédéric Mathot, Erwan Bourlès

Rational Design of Liquid Protein Formulations: Application of Biophysical Stability Predictors and Descriptors to Reformulate Biotherapeutics

Rational Design of Liquid Protein Formulations: Application of Biophysical Stability Predictors and Descriptors to Reformulate Biotherapeutics

Rational Design of Liquid Protein Formulations: Application of Biophysical Stability Predictors and Descriptors to Reformulate Biotherapeutics

+3

byKevin Mattison, Jonathan Mehtalaand 3 more

eBook: Alternative Delivery of Biologics — Underdogs Pursue Roads Less Traveled

eBook: Alternative Delivery of Biologics — Underdogs Pursue Roads Less Traveled

eBook: Alternative Delivery of Biologics — Underdogs Pursue Roads Less Traveled

byAngelo DePalma

Conference Report: The Drug Product Track at 2017’s BioProcess International Conference and Exhibition in Boston, MA

Conference Report: The Drug Product Track at 2017’s BioProcess International Conference and Exhibition in Boston, MA

Conference Report: The Drug Product Track at 2017’s BioProcess International Conference and Exhibition in Boston, MA

Polysorbates, Biotherapeutics, and Anaphylaxis: A Review

Polysorbates, Biotherapeutics, and Anaphylaxis: A Review

Polysorbates, Biotherapeutics, and Anaphylaxis: A Review

byEdward Maggio

Aggregation from Shear Stress and Surface Interaction: Molecule-Specific or Universal Phenomenon?

Aggregation from Shear Stress and Surface Interaction: Molecule-Specific or Universal Phenomenon?

Aggregation from Shear Stress and Surface Interaction: Molecule-Specific or Universal Phenomenon?

+6

byDouglas Nesta, Tatiana Nandaand 6 more

Validation of Controlled Freezing and Thawing: A 9-L Bottle Study

Process Monitoring and Controls

Validation of Controlled Freezing and Thawing: A 9-L Bottle Study

Validation of Controlled Freezing and Thawing: A 9-L Bottle Study